News
A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...
A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...
Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best CRISPR stocks to buy. On June 24, Thermo Fisher Scientific Inc.
A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...
1d
News Medical on MSNStudy unveils powerful strategy to rejuvenate effectiveness of CAR T cell therapy against glioblastomaA team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...
During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...
Previously, due to the risk of cytokine release syndrome and neurological toxicities, many CAR T-cell therapies included a REMS requirement.
1d
News-Medical.Net on MSNLeukemia-on-a-chip offers breakthrough in personalized cancer treatmentA team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...
2d
Interesting Engineering on MSNCredit-card-sized chip reveals how immune cells hunt and kill cancer in real timeEngineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $69.0, a high ...
A Martin County family with a child fighting rare cancer is getting help from the community to get treatment abroad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results